DOLORES SOLIS: Open Payments
NPI 1760676191 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 13 payments from 6 companies in 2025. Trend: 2023 $294 · 2024 $996 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Alkermes, Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
Products named: ARISTADA, COBENFY, UZEDY, FANAPT, REXULTI, AUSTEDO XR, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
